Search Within

Ariela Noy

Formats
  1. Meeting Abstract (204)
  2. Journal Article (143)
  3. Research Letter (10)
  4. Book Section (6)
  5. Review (6)
  6. Editorial (2)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (373)
  2. Department of Medicine (373)
  3. Hematologic Malignancies, Division of (373)
  4. Lymphoma (373)
  5. Survivorship Research (163)
  6. Population Sciences Research Program (150)

More Groups

People
  1. Andrew Zelenetz (187)
  2. Paul Hamlin (144)
  3. David Straus (139)
  4. Steven Horwitz (138)
  5. Maria Palomba (131)
  6. Alison Moskowitz (118)

More People

Years
  1. 2025 (9)
  2. 2024 (27)
  3. 2023 (24)
  4. 2022 (15)
  5. 2021 (30)
  6. 2020 (26)

More Years

Publications
  1. Blood (166)
  2. Journal of Clinical Oncology (42)
  3. Hematological Oncology (19)
  4. Leukemia and Lymphoma (15)
  5. Blood Advances (13)
  6. Annals of Oncology (12)

More Publications

Publishers
  1. American Society of Hematology (179)
  2. American Society of Clinical Oncology (43)
  3. Wiley Blackwell (23)
  4. Elsevier Inc. (21)
  5. Taylor & Francis Group (15)
  6. Ferrata Storti Foundation (12)

More Publishers

Results (373)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent
    Journal Article

    Teckie, S.; Qi, S.; Lovie, S.; Navarrett, S.; Hsu, M.; Noy, A.; Portlock, C.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation
    Journal Article

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Lia Palomba, M.; Drullinsky, P. R.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Elstrom, R.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Acquired immunodeficiency syndrome
    Book Section

    Noy, A.; Gulick, R. M.
    In Greer, J. P.; Arber, D. A.; Glader, B.; List, A. F.; Means, R. T. Jr; Paraskevas, F.; Rodgers, G. M.; Foerster, J. (Eds.) Wintrobe's Clinical Hematology. 13th ed (2014)

    Fulltext@MSK | Save
  • CNS involvement in patients with AIDS-related lymphomas
    Meeting Abstract

    Joshi, J.; Mounier, N.; Xue, X. N.; Wang, D.; Ribera, J. M.; Wyen, C.; Dunleavy, K.; Little, R. F.; Wilson, W. H.; Noy, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Sexual dysfunction in women with lymphoma: Prevalence and etiologies
    Meeting Abstract

    Goldfarb, S. B.; Jackson, T.; Carter, J.; Dickler, M. N.; Noy, A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • High frequency of identical lymphoma clones detected in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphomas: Prospective multicenter trial of the AIDS Malignancy Consortium (AMC 064)
    Meeting Abstract

    Wagner-Johnston, N.; Lee, J. Y.; Silver, S.; Noy, A.; Mims, M. P.; Pepin, F.; Moorhead, M.; Faham, M.; Ambinder, R. F.
    Blood (2014)

    Fulltext@MSK | Save
  • AMC075: The combination of vorinostat with chemotherapy and rituximab is tolerable and feasible in HIV-related B-cell non-Hodgkin's lymphoma with high-risk features
    Meeting Abstract

    Ramos, J. C.; Sparano, J.; Moore, P.; Lee, J. Y.; Rudek, M. A.; Ambinder, R. F.; Cesarman, E.; Noy, A.; Mitsuyasu, R. T.
    Blood (2014)

    Fulltext@MSK | Save
  • Dose-adjusted EPOCH plus /- rituximab in older patients with high grade diffuse large B-cell lymphoma, Burkitt and T-cell lymphoma: An effective regimen with acceptable toxicity profile
    Meeting Abstract

    Owens, C. N.; Migliacci, J. C.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Younes, A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save